European Archives - Page 226 of 1108 - European Medical Journal

MRI-Based System Improves Diagnosis of Extremity Infections

A study showed a new MRI-based Musculoskeletal Infection Reporting and Data System, designed to enhance diagnostic accuracy for peripheral extremity infections.

Sanofi's MS drug delivers surprising Phase III results

It’s been both a good and bad week for French pharmaceutical company Sanofi, as their MS drug candidate, received mixed trial results.

Polycystic Ovary Syndrome Linked to Disordered Eating

Women with polycystic ovary syndrome are at a greater risk for developing disordered eating according to the results of a meta-analysis.

Penile Curvature Study Reveals New Peyronie’s Disease Classification

A new classification system for Peyronie’s disease, has been introduced in a recent study aiming to better define the subtypes and stages of this condition

AI Could Lighten Urologists’ Administrative Workload

A study has suggested that generative AI tools could potentially reduce the time burden of electronic health record management for urologists.

Optimising Methotrexate for Arthritis

Listen to three experts attending EULAR 2024, who provide their recommendations on how to optimise methotrexate therapy use across various arthritis types.

Patient Perspectives of Navigating Life with Primary Biliary Cholangitis

Transplant hepatologist Eleonora De Martin and patient advocate Ingo van Thiel, co-host this bonus episode to support the continuing education of healthcare professionals working with primary biliary cholangitis. NX-GBL-LNR-AUDI-240001 | May 2024

Primary Parotid Tuberculosis Presenting as a Malignancy

Tuberculosis is a well-known endemic disease in India; however, extra-pulmonary tuberculosis in the form of single parotid gland…

Webinar Series: Keep up to date with the genomic profiling in precision oncology

Sign up to three educational webinars that will cover the latest developments in the precision medicine landscape in non-small cell lung cancer and focus on the key role of next-generation sequencing based biomarker profiling.

SHAM-PVI Trial Confirms Efficacy of Ablation Procedure for Atrial Fibrillation: ESC 2024

ESC 2024: The SHAM-PVI trial confirms that catheter ablation significantly reduces atrial fibrillation burden and improves quality of life compared to a sham treatment.